Mark Thompson has joined Covington’s London office as a partner and co-chair of the firm’s global private equity practice. Thompson has an established private equity practice in London, where he has been advising on transactions in a variety of industries, including life sciences, energy, telecommunications, electronic payments, banking, finance and
BTIG has appointed Jared Sender, MD as a Managing Director within its Healthcare Investment Banking division. Sender will focus on investment banking opportunities across the healthcare industry. Sender is uniquely positioned to evaluate multiple facets of the healthcare universe as a result of his experiences working various positions in the
British Patient Capital has participated in the USD60 million Series B funding round of Paragraf, a Cambridge-based graphene-based electronics company. This investment is being made through British Patient Capital’s Future Fund: Breakthrough programme, a GBP375 million initiative where British Patient Capital co-invests alongside private sector investors in later stage R&D-intensive
Blue Horizon, a pure play impact investor in the future of food, has made its first investment in plant cell culture. Blue Horizon has invested in California Cultured, a Davis, California-based plant cell culture company pioneering a promising new application for cellular agriculture. Similar to cultivated meat, plant cell culture
Baronsmead Venture Trust and Baronsmead Second Venture Trust (the Baronsmead VCTs), managed by specialist alternative asset manager Gresham House, have raised a further GBP75 million. As with previous years, this 2022 tax year fundraise closed ahead of schedule and was oversubscribed beyond its initial GBP50 million target, reflecting strong investor
McAfee Corp, a specialist in online protection, has been acquired by an investor group led by Advent International Corporation (Advent) and funds advised by Permira, Crosspoint Capital Partners (Crosspoint), Canada Pension Plan Investment Board (CPP Investments), GIC Private Limited (GIC), and a wholly-owned subsidiary of the Abu Dhabi Investment Authority
Syndesi Therapeutics (Syndesi), a portfolio company of international life sciences investor Novo Holdings, has been acquired by AbbVie for up to USD1 billion in total deal value with USD130 million upfront. Syndesi was created in 2018 as the result of a close collaboration between Novo Seeds, the company creation arm
Pemberton, an alternative credit specialist, has appointed Rob Reynolds to head its new Collateralised Loan Obligation (CLO) platform.
iCapital, a global fintech platform providing access and efficiency in alternative investing for the asset and wealth management industries, has acquired Bank of Singapore’s in-house private market feeder fund platform. With the deal, iCapital takes over the management and operation of the bank’s private market feeder funds while Bank of
Seward & Kissel LLP was named the Best Law Firm Overall at Hedgeweek’s inaugural US Digital Assets Awards, which recognised excellence among fund managers and service providers in the emerging digital assets space. The firm was also shortlisted for Best Law Firm for Fund Structuring. Honorees were selected based on
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
